3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 4
1
Status
Recruiting
2
Not yet recruiting
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
3
Sponsor
Cancer Type
Classical hematology
3
Conditions
Breast Neoplasms
311
Carcinoma, Non-Small-Cell Lung
276
Neoplasms
255
Prostatic Neoplasms
216
Colorectal Neoplasms
196
Lung Neoplasms
153
Multiple Myeloma
148
Neoplasm Metastasis
135
Ovarian Neoplasms
126
Leukemia, Myeloid, Acute
123
Pancreatic Neoplasms
116
Melanoma
102
Squamous Cell Carcinoma of Head and Neck
97
Recurrence
85
Endometrial Neoplasms
82
Carcinoma, Renal Cell
80
Glioblastoma
78
Lymphoma, Non-Hodgkin
77
Stomach Neoplasms
73
Precursor Cell Lymphoblastic Leukemia-Lymphoma
72
Lymphoma
72
Carcinoma, Hepatocellular
72
Glioma
65
Brain Neoplasms
65
Uterine Cervical Neoplasms
63
Sarcoma
63
Head and Neck Neoplasms
63
Triple Negative Breast Neoplasms
59
Leukemia, Lymphocytic, Chronic, B-Cell
58
Urinary Bladder Neoplasms
55
Interventions
apixaban
1
Rosuvastatin Calcium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Interventional
×
Pulmonary Embolism
×
30 days
×
Clear all
NCT07303816
2026-06-01
STAT-CAT
Brigham and Women's Hospital
Phase 4
Not yet recruiting
4,000 enrolled
NCT07493304
2026-05-29
ROXI-CAT-II
Regeneron Pharmaceuticals
Phase 3
Recruiting
1,600 enrolled
NCT07410117
2026-05-27
ROXI-CAT-I
Regeneron Pharmaceuticals
Phase 3
Recruiting
1,120 enrolled